The serum levels of the soluble isoforms of gp130, IL6R, TNFR1, and TNFR2 were significantly lower in OSA patients relative to control subjects, but OSA patients receiving airways therapy had levels indistinguishable from controls. This evidence concerns the gene IL6R and obstructive sleep apnea syndrome.